Rare diseases
Investigational molecules
Locations
Back to Germany1 128 clinical trials in Hamburg, Germany across 19 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)A study testing how well cagrilintide and semaglutide help people with overweight or obesity lose weight
GermanyA study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
GermanyStudy of Rocatinlimab with Topical Treatments for Adults with Moderate to Severe Atopic Dermatitis
GermanyStudy of lavender oil (Silexan) in patients with mild to moderate major depressive disorder comparing its effectiveness to placebo
GermanyStudy of oral and injectable NNC0487-0111 (Amycretin) to find the best dose for blood sugar control in adults with type 2 diabetes taking metformin with or without SGLT2 inhibitor
GermanyLong-term study of dabrafenib and trametinib in children and adolescents with cancers that have V600 mutation
GermanyStudy of alpelisib in children and adults with PIK3CA-Related Overgrowth Spectrum (PROS)
GermanyStudy of Datopotamab Deruxtecan with or without Durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy
GermanyStudy of SAR441566 and methotrexate in adults with moderate to severe rheumatoid arthritis
GermanyStudy of luxdegalutamide and abiraterone combination in adult men with metastatic hormone-sensitive prostate cancer
GermanyComparing weekly insulin icodec and daily insulin glargine with insulin aspart in adults with type 1 diabetes: a 26-week study of blood sugar control
GermanyStudy of Tibulizumab to Treat Adults with Hidradenitis Suppurativa
GermanyThe busiest research cities in the country
What the registry says about research in the country
Current clinical trials focusing on innovative treatments for metastatic prostate cancer, colorectal cancer, and breast cancer. Studies are evaluating new therapeutic combinations and targeted approaches for improved patient outcomes.
Comprehensive vaccine development programs targeting respiratory syncytial virus, cytomegalovirus, and meningococcal infections. Research focuses on both adult and pediatric populations.
Groundbreaking research in treating acute cerebral ischemic stroke with innovative therapies. Studies are evaluating functional outcomes and safety profiles of new therapeutic agents.
Clinical investigations addressing vaginal atrophy and contraceptive technologies. Research includes novel delivery systems and hormone-based treatments for postmenopausal conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
